HEALTH Stock Overview
A health technology company, offers health data platform that detects disease risks.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Nightingale Health Oyj Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €2.29 |
52 Week High | €2.39 |
52 Week Low | €0.80 |
Beta | 0.47 |
11 Month Change | 38.37% |
3 Month Change | 116.04% |
1 Year Change | 172.62% |
33 Year Change | -60.52% |
5 Year Change | n/a |
Change since IPO | -55.53% |
Recent News & Updates
Shareholder Returns
HEALTH | FI Healthcare | FI Market | |
---|---|---|---|
7D | -0.4% | 1.1% | 0.2% |
1Y | 172.6% | 1.9% | -6.2% |
Return vs Industry: HEALTH exceeded the Finnish Healthcare industry which returned 1.9% over the past year.
Return vs Market: HEALTH exceeded the Finnish Market which returned -6.2% over the past year.
Price Volatility
HEALTH volatility | |
---|---|
HEALTH Average Weekly Movement | 14.9% |
Healthcare Industry Average Movement | 4.8% |
Market Average Movement | 4.3% |
10% most volatile stocks in FI Market | 8.1% |
10% least volatile stocks in FI Market | 2.8% |
Stable Share Price: HEALTH's share price has been volatile over the past 3 months.
Volatility Over Time: HEALTH's weekly volatility has increased from 10% to 15% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | 81 | Teemu Suna | nightingalehealth.com |
Nightingale Health Oyj, a health technology company, offers health data platform that detects disease risks. The company’s blood analysis technology measures various biomarkers from a single blood sample and identifies personal risks of disease using health data assets. It serves healthcare industry and researchers in Finland, the United Kingdom, rest of Europe, and internationally.
Nightingale Health Oyj Fundamentals Summary
HEALTH fundamental statistics | |
---|---|
Market cap | €138.18m |
Earnings (TTM) | -€18.06m |
Revenue (TTM) | €3.65m |
37.8x
P/S Ratio-7.7x
P/E RatioIs HEALTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HEALTH income statement (TTM) | |
---|---|
Revenue | €3.65m |
Cost of Revenue | €884.00k |
Gross Profit | €2.77m |
Other Expenses | €20.83m |
Earnings | -€18.06m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 20, 2024
Earnings per share (EPS) | -0.30 |
Gross Margin | 75.81% |
Net Profit Margin | -494.23% |
Debt/Equity Ratio | 1.7% |
How did HEALTH perform over the long term?
See historical performance and comparison